LYCA Buy Disclosure
Venrock Healthcare Capital Partners Iii, L.p. · SEC Form 4 · Filed Oct 27, 2026
Buy
Calculated transaction value
$225.56K
Venrock Healthcare Capital Partners Iii, L.p. 10% owner
LYCA
Transaction date
Oct 27, 2026
Public filing date
Oct 27, 2026
Filing lag
Filed same day
LYCA daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 8,729 shares @ $25.84
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001231919-26-001503
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$37.65M
Buys / sales
6 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lycia Therapeutics, Inc. LYCA | Buy | Oct 27, 2026 | $833.84K |
| Lycia Therapeutics, Inc. LYCA Current | Buy | Oct 27, 2026 | $225.56K |
| Lycia Therapeutics, Inc. LYCA | Conversion | Oct 26, 2026 | Not reported |
| Lycia Therapeutics, Inc. LYCA | Conversion | Oct 26, 2026 | $0 |
| Lycia Therapeutics, Inc. LYCA | Conversion | Oct 26, 2026 | $0 |
| Lycia Therapeutics, Inc. LYCA | Buy | Oct 26, 2026 | $35M |
| Lycia Therapeutics, Inc. LYCA | Buy | Oct 26, 2026 | $222.8K |
| Lycia Therapeutics, Inc. LYCA | Buy | Oct 23, 2026 | $630.7K |
| Lycia Therapeutics, Inc. LYCA | Buy | Oct 23, 2026 | $740.98K |